Nadler Financial Group’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,375
| Closed | -$9.45K | – | 119 |
|
|
2023
Q4 | $9.45K | Hold |
1,375
| – | – | ﹤0.01% | 106 |
|
|
2023
Q3 | $8.66K | Hold |
1,375
| – | – | ﹤0.01% | 108 |
|
|
2023
Q2 | $11.4K | Hold |
1,375
| – | – | ﹤0.01% | 116 |
|
|
2023
Q1 | $6.05K | Hold |
1,375
| – | – | ﹤0.01% | 114 |
|
|
2022
Q4 | $8.11K | Buy |
+1,375
| New | +$8.11K | ﹤0.01% | 110 |
|
|
2022
Q1 | – | Sell |
-1,100
| Closed | -$86K | – | 135 |
|
|
2021
Q4 | $86K | Buy |
+1,100
| New | +$86K | 0.01% | 132 |
|